Bart Filius insider trades

Open-market stock purchases and sales by Bart Filius, Director at ProQR Therapeutics NV, from SEC Form 4 filings since Jun 26, 2026.

Recent trades

DateStockTradeValue
Jun 26, 2026PRQR ProQR Therapeutics NVBought$231K

Companies traded

  • PRQR ProQR Therapeutics NV: 1 buy, last Jun 26, 2026

Get free alerts when Bart Filius files a new trade →